Results 91 to 100 of about 145,313 (292)

Prevalence and incidence of deep venous thrombosis and pulmonary embolism in 2 regions in Turkey (A sub-analysis of CAT-TR study)

open access: yesTurkish Journal of Vascular Surgery, 2023
Aim: Venous thromboembolism (VTE) is a relatively common public health problem. In addition to increasing mortality due to complications, it also causes an increase in the cost of the country's economy and loss of labor due to the morbidity it ...
Hakkı Tankut Akay   +6 more
doaj  

Sex-based disparities in venous thromboembolism outcomes: A National Inpatient Sample (NIS)-based analysis [PDF]

open access: bronze, 2017
Ariela L. Marshall   +9 more
openalex   +1 more source

Safety of Baricitinib for the Treatment of Atopic Dermatitis in Adults Over a Median of 1.6 and up to 4.6 Years Treatment: Final Integrated Analysis of Eight Clinical Trials

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Background Baricitinib is a selective Janus kinase (JAK)1/JAK2 inhibitor approved in more than 70 countries for the treatment of moderate‐to‐severe atopic dermatitis (AD) in adults, and in over 30 countries for adolescents and children from age 2 years with moderate‐to‐severe AD, who are candidates for systemic therapy.
Antonio Costanzo   +11 more
wiley   +1 more source

COAGULOPATHY IN BETA-THALASSEMIA: CURRENT UNDERSTANDING AND FUTURE PERSPECTIVES

open access: yesMediterranean Journal of Hematology and Infectious Diseases, 2009
<p class="MsoNormal" style="text-align: justify; line-height: 200%; margin: 0cm 0cm 0pt; mso-layout-grid-align: none;"><span style="line-height: 200%; font-family: ";Times New Roman";,";serif";; font-size: 12pt;" lang="EN-US">As the life ...
Alessia Marcon   +3 more
doaj  

New Biologic and Small Molecule Therapies for Hidradenitis Suppurativa

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Hidradenitis suppurativa (HS) is an inflammatory skin disease that has historically been underdiagnosed and, until recently, under‐researched. Furthermore, the pathophysiology of HS is complex, and not fully understood. Just three biologic medications—adalimumab (anti‐TNF‐α), secukinumab (anti‐IL17A) and bimekizumab (anti‐IL17A/F) are licensed
Emily Pender   +2 more
wiley   +1 more source

Patterns and Predictors of Use of Anticoagulants for the Treatment of Venous Thromboembolism Following Approval of Rivaroxaban [PDF]

open access: bronze, 2015
Roxanne Dault   +6 more
openalex   +1 more source

A novel knee implant for total knee arthroplasty meets expectations at 10 years. First long‐term follow‐up report of clinical outcomes and survivorship

open access: yesKnee Surgery, Sports Traumatology, Arthroscopy, EarlyView.
Abstract Purpose Achieving a “forgotten knee” after total knee arthroplasty (TKA) remains a primary goal in modern knee replacement surgery. Anatomic implant designs aim to replicate native knee anatomy and kinematics, potentially improving patient satisfaction and functional outcomes.
Alice Montagna   +6 more
wiley   +1 more source

Imageless and image‐based robotic‐assisted total knee arthroplasty achieve equivalent radiographic accuracy: A randomised controlled trial

open access: yesKnee Surgery, Sports Traumatology, Arthroscopy, EarlyView.
Abstract Purpose Robotic‐assisted total knee arthroplasty systems offer both image‐based and imageless workflows, but their comparative accuracy remains unclear. The robotic surgical assistant (ROSA) system uniquely provides both approaches within a single platform.
Rapeepat Narkbunnam   +5 more
wiley   +1 more source

Tratamiento quirúrgico de la enfermedad valvular cardiaca de predominio izquierdo, en un hospital de referencia nacional de Lima, Perú

open access: yesRevista Peruana de Medicina Experimental y Salud Pública
Objetivos. Describir las características preoperatorias, intraoperatorias y posoperatorias de los pacientes con enfermedad valvular cardiaca de predominio izquierdo (EVCPI) tratados en un servicio de cirugía de tórax y cardiovascular de un hospital de ...
Julio C. Vasquez   +3 more
doaj  

Home - About - Disclaimer - Privacy